KAPA
Kairos Pharma, Ltd.
There isn't enough reported data to score KAPA yet.
KAPA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
KAPA's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
KAPA PE Valuation
KAPA has no meaningful PE right now: it lost money over the past year.
KAPA Forward outlook
There aren't enough analyst estimates for KAPA to show an outlook.
KAPA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$1.82 | -$1.23 |
| Q2 2024 | -$1.32 | -$0.77 |
| Q1 2024 | -$1.34 | -$0.68 |
| Q4 2023 | -$1.22 | -$0.50 |
KAPA lost $1.96 per share over the past year, a bigger loss than the year before.
KAPA Quarterly Revenue
KAPA's revenue is shrinking: $0 last quarter.
KAPA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1M | -$207K |
| Q1 2026 | -$1M | -$322K |
| Q4 2025 | -$1.1M | +$719K |
| Q2 2025 | -$805K | -$637K |
| Q1 2025 | -$714K | -2083% |
| Q4 2024 | -$1.8M | -2832% |
| Q2 2024 | -$168K | -$100K |
| Q1 2024 | $36K | +$44K |
KAPA has burned cash in most quarters: −$4M over the past year, against −$3M the year before.
KAPA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2% | +58.6K shares |
| 1 year | +24% | +601K shares |
| 3 years | +107% | +1.6M shares |
KAPA has 3M diluted shares, up 24% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
KAPA Net Leverage
KAPA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
KAPA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 23.5 | Oversold |
| Stochastic | 2.0 | Oversold |
KAPA's weekly RSI is 23 (oversold) and its Stochastic is 2 (oversold).
KAPA PE vs Healthcare Sector
KAPA has no meaningful PE right now: it lost money over the past year.
KAPA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.84 | 43% below |
| 20 week MA | $1.61 | 70% below |
| 50 week MA | $3.25 | 85% below |
| 100 week MA | $5.32 | 91% below |
KAPA is in a downtrend: it's below all four of its weekly moving averages, and 91% below its 100-week average.
KAPA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $15.3 | $11.8 | -23% |
| 2025 | $11.8 | $4.96 | -58% |
| 2026 YTD | $4.96 | $0.48 | -90% |
KAPA has finished every year since 2024 lower, and it's down 90% so far in 2026.